| |
|
|
|
Celldex Therapeutics Inc.  
|
|
12.94 0.83 (0.07%) |
09-18 16:00 |
|
Open: |
12.11 |
Pre close: |
12.11 |
Target:
|
15.69
|
|
High: |
13.105 |
Low: |
12.11 |
Resistance:
|
13.43
15.69
|
|
Volume: |
1,322,190 |
Market Cap: |
555M |
Support:
|
11.10
9.66
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
12.02
 |
MACD |
MACD(12,26):
|
0.26  |
|
MA(20): |
11.61 |
Signal(12,26,9): |
0.22 |
|
MA(100): |
8.54 |
Stochastic Oscillator |
%K(14,3):
|
63.48 |
|
MA(250): |
4.77 |
%D(3): |
64.86 |
|
Average Volume(K) |
3-Month: |
71778
|
52-Week |
High:
|
13.91 |
|
10-Days: |
66625 |
Low: |
1.50 |
|
RSI |
RSI(14):
|
51.91 |
Change(%): |
367.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.560 |
Return on Equity (ttm) |
-26.1 |
Shares Out. (M) |
39.13 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-16.2 |
Shares Float (M) |
29.71 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.19 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-67.0 |
% Held by Institutions |
23.25 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
-0.999 |
Shares Short (K) |
2430 |
|
Book Value (p.s.) |
6.100 |
EBITDA (p.s.) |
-1.216 |
P/E |
-4.58 |
|
Sales Per Share |
0.112 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.92 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-45.47 |
P/S |
104.32 |
|
Operating Margin |
-1188.22 |
Levered Free Cash Flow
(M) |
-25.09 |
P/CF |
-10.09 |
|
|
|
|
|
|
